IGC Pharma
IGC · NYSE American
$0.245−$0.0209 (−7.86%)TodayMarket closed ·
Prev close $0.2659
Who owns IGC
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 33.6% of IGC’s shares.
- Bradbury Asset Management (Hong Kong) Limited16.9%
- Mukunda (Ram)7.4%
- Grimaldi (Claudia)3.3%
- Prins (Richard)1.5%
- Next 6 largest institutions4.6%
- All other shareholders66.4%
| Holder | Shares | % of shares |
|---|---|---|
| Bradbury Asset Management (Hong Kong) Limited | 17.62M | 16.89% |
| Mukunda (Ram) | 7.74M | 7.41% |
| Grimaldi (Claudia) | 3.42M | 3.28% |
| Prins (Richard) | 1.54M | 1.48% |
| Moran (James P) | 1.24M | 1.18% |
| Geode Capital Management, L.L.C. | 879.39K | 0.84% |
| Vanguard Capital Management, LLC | 814.91K | 0.78% |
| BlackRock Institutional Trust Company, N.A. | 703.80K | 0.67% |
| AdvisorShares Investments, LLC | 678.48K | 0.65% |
| Citadel Advisors LLC | 437.32K | 0.42% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Extended Market Index Fund | 814.91K | 0.78% |
| AdvisorShares Psychedelics ETF | 812.35K | 0.78% |
| Fidelity Extended Market Index Fund | 464.26K | 0.44% |
| Fidelity Total Market Index Fund | 98.55K | 0.09% |
| Fidelity Series Total Market Index Fund | 95.37K | 0.09% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of IGC in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| GRIMALDI CLAUDIA | Gift | 150.00K | — |
| Mukunda Ram | Gift | 100.00K | — |
| Mukunda Ram | Gift | 100.00K | — |
| GRIMALDI CLAUDIA | Award | 2.05M | $553.06K |
| Mukunda Ram | Award | 2.23M | $601.15K |
Short interest
Settled Sep 30, 2026
- Shares short
- 931.51K
- Days to cover
- 1.44
- % of shares outstanding
- 0.89%
- Average daily volume
- 648.27K
- Change since last report
- −13.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.